
Overview
Background
I am a clinician scientist and academic leader with research in melanoma cell biology and experimental melanoma therapy. I received my degree in medicine from the University of Heidelberg, Germany (1990-1998). I graduated summa cum laude with a PhD in Cell Biology from the University of Heidelberg (1993-1999) and trained in clinical dermatology at the University of Hamburg, Germany (1999-2003). In 2003 I moved to Philadelphia, PA, to work as a post-doctoral fellow in Meenhard Herlyn’s lab at The Wistar Institute (2003-2007). From there I was recruited as an associate faculty member to the Centenary Institute/University of Sydney (2007-2013). In 2013 I commenced a position as Associate Professor for Cutaneous Oncology at University of Queensland Diamantina Institute (now Frazer Institute) and was promoted to full Professor in April 2016.
Availability
- Professor Nikolas Haass is:
- Available for supervision
Fields of research
Qualifications
- Doctoral Diploma, Ruprecht Karls Universität Heidelberg
Research impacts
Using cutting-edge technology, including real-time cell cycle imaging in 3D culture and in vivo, my team studies the role of dynamic melanoma heterogeneity in melanomagenesis with the goal to develop novel therapeutic approaches by simultaneously targeting different tumor cell subpopulations. My laboratory and our team are in the unique position to combine sophisticated imaging and biosensor approaches with biochemical methods to provide unprecedented insight to the mechanisms of tumor heterogeneity, tumor-stroma interactions and cancer immunology.
My contribution to the field is best evidenced by 97 original papers and invited reviews in leading biomedical journals. Many of our papers have a large impact in the field (>7500 citations in total, and 19 papers cited >100 times each). The papers in Mol Cancer Ther (2006, cited >500x), Cancer Res (2007, cited 265x) and PNAS (2008, cited 1500x) were evaluated by Faculty 1000 Biology as recommended or exceptional, respectively.
Works
Search Professor Nikolas Haass’s works on UQ eSpace
2014
Journal Article
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy
Mohana-Kumaran, Nethia, Hill, David S., Allen, John D. and Haass, Nikolas K. (2014). Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy. Pigment Cell and Melanoma Research, 27 (4), 525-539. doi: 10.1111/pcmr.12242
2014
Conference Publication
Defining the mode of melanoma's proliferative heterogeneity by real-time cell cycle imaging
Haass, N. K., Beaumont, K., Anfosso, A., Hill, D., Jurek, R., Sharp, D., Mrass, P., Munoz, M., Kinjyo, I. and Weninger, W. (2014). Defining the mode of melanoma's proliferative heterogeneity by real-time cell cycle imaging. 41st Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Cologne, Germany, 13-15 March 2014. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12314
2014
Book Chapter
The Grey-headed Albatross conundrum at the Australian east coast
Haass, Nikolas K. (2014). The Grey-headed Albatross conundrum at the Australian east coast. The Petrel: Annual Report for Southport The Brisbane Seabird Study Group SOSSA, Northern Sector. (pp. 96-107) edited by Paul Walbridge. Brisbane, QLD Australia: SOSSA.
2014
Conference Publication
Rose Bengal melanoma therapy: Phototoxicity versus intrinsic cytotoxicity
Nascimento, P. R. B. B., Baesler, K., Knuever, J., Douglas, G., Anfosso, A., Weninger, W. and Haass, N. K. (2014). Rose Bengal melanoma therapy: Phototoxicity versus intrinsic cytotoxicity. The Australasian College of Dermatologists 47th Annual Scientific Meeting, Melbourne, VIC Australia, 18-21 May 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12174
2013
Journal Article
Modeling Melanoma In Vitro and In Vivo
Beaumont, Kimberley A., Mohana-Kumaran, Nethia and Haass, Nikolas K. (2013). Modeling Melanoma In Vitro and In Vivo. Healthcare, 2 (1), 27-46. doi: 10.3390/healthcare2010027
2013
Journal Article
DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.
Pavey, Sandra, Spoerri, Loredana, Haass, Nikolas K. and Gabrielli, Brian (2013). DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.. Pigment Cell and Melanoma Research, 26 (6), 805-816. doi: 10.1111/pcmr.12136
2013
Journal Article
A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy
Tong, P. L., Qin, J., Cooper, C. L., Lowe, P. M., Murrell, D. F., Kossard, S., Ng, L. G., Roediger, B., Weninger, W. and Haass, N. K. (2013). A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy. British Journal of Dermatology, 169 (4), 869-879. doi: 10.1111/bjd.12430
2013
Journal Article
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells
Stehn, Justine R., Haass, Nikolas K., Bonello, Teresa, Desouza, Melissa, Kottyan, Gregg, Treutlein, Herbert, Zeng, Jun, Nascimento, Paula R. B. B., Sequeira, Vanessa B., Butler, Tanya L., Allanson, Munif, Fath, Thomas, Hill, Timothy A., McCluskey, Adam, Schevzov, Galina, Palmer, Stephen J., Hardeman, Edna C., Winlaw, David, Reeve, Vivienne E., Dixon, Ian, Weninger, Wolfgang, Cripe, Timothy P. and Gunning, Peter W. (2013). A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Research, 73 (16), 5169-5182. doi: 10.1158/0008-5472.CAN-12-4501
2013
Conference Publication
Loss of Noxa and Puma have inverse effects on melanomagenesis in a predisposed, genetically-defined mouse melanoma model
Mohana-Kumaran, N., Lucas, K. M., Roediger, B., Scolyer, R. A., Weninger, W., Allen, J. D. and Haass, N. K. (2013). Loss of Noxa and Puma have inverse effects on melanomagenesis in a predisposed, genetically-defined mouse melanoma model. International Investigative Dermatology Meeting, Edinburgh Scotland, May 08-11, 2013. NEW YORK: NATURE PUBLISHING GROUP.
2013
Conference Publication
MITF regulates the proliferative architecture of the melanoma microenvironment
Haass, N. K., Beaumont, K. A., Anfosso, A., Hill, D. S., Jurek, R. K., Mrass, P., Munoz, M., Kinjyo, I., Miyawaki, A. and Weninger, W. (2013). MITF regulates the proliferative architecture of the melanoma microenvironment. International Investigative Dermatology Meeting, Edinburgh Scotland, May 08-11, 2013. NEW YORK: NATURE PUBLISHING GROUP.
2013
Conference Publication
Cancer cells and galaxies - novel image analysis techniques identify subcompartment-specific cell cycle dynamics and motility in melanoma
Beaumont, K. A., Anfosso, A., Hill, D. S., Jurek, R. J., Mrass, P., Munoz, M. M., Kinjyo, I., Miyawaki, A., Weninger, W. and Haass, N. K. (2013). Cancer cells and galaxies - novel image analysis techniques identify subcompartment-specific cell cycle dynamics and motility in melanoma. 40th Annual Meeting of the Association-of-Dermatological-Research, Dessau Germany, Mar 14-16, 2013. HOBOKEN: WILEY-BLACKWELL.
2013
Journal Article
The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance
Wroblewski, David, Mijatov, Branka, Mohana- Kumaran, Nethia, Lai, Fritz, Gallagher, Stuart J., Haass, Nikolas K., Zhang, Xu Dong and Hersey, Peter (2013). The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance. Carcinogenesis, 34 (2), 237-247. doi: 10.1093/carcin/bgs330
2013
Journal Article
Melanoma's connections to the tumour microenvironment
Brandner, Johanna M. and Haass, Nikolas K. (2013). Melanoma's connections to the tumour microenvironment. Pathology, 45 (5), 443-452. doi: 10.1097/PAT.0b013e328363b3bd
2013
Conference Publication
Induction of Endoplasmic Reticulum Stress as a Strategy for Melanoma Therapy
Hill, D., Beaumont, K., Anfosso, A., Miyawaki, A., Weninger, W., Lovat, P. and Haass, N. (2013). Induction of Endoplasmic Reticulum Stress as a Strategy for Melanoma Therapy. 8th World Congress of Melanoma, 9th Congress of the European Association of Dermatology (EADO), 7th Interdisciplinary Melanoma/Skin Cancer Meeting, 3rd European Post-Chicago Melanoma Meeting 2013, Hamburg, German, 77 - 20 July 2013. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/ddg.12162
2013
Conference Publication
ZO-1 kontrolliert die Invasivität von Melanomzellen
Pandjaitan, M. A. T., Bohner, C., Zorn-Kruppa, M., Vidal-y-Sy, S., Haass, N. K., Moll, I and Brandner, J. M. (2013). ZO-1 kontrolliert die Invasivität von Melanomzellen. 23. Deutscher Hautkrebskongress 2013 und ADO-Jahrestagung, Essen, 26 - 28 September 2013. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/ddg.12189
2013
Conference Publication
Rose Bengal - Phototoxicity versus Intrinsic Cytotoxicity
Nascimento, P., Baesler, K., Knuever, J., Douglas, G., Anfosso, A., Weninger, W. and Haass, N. (2013). Rose Bengal - Phototoxicity versus Intrinsic Cytotoxicity. 8th World Congress of Melanoma, 9th Congress of the European Association of Dermatology (EADO), 7th Interdisciplinary Melanoma/Skin Cancer Meeting, 3rd European Post-Chicago Melanoma Meeting 2013, Hamburg, Germany, 17 - 20 July 2013. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/ddg.12160
2013
Conference Publication
BRAF New World
Haass, N. (2013). BRAF New World. 46th Annual Scientific Meeting, Sydney, New South Wales, 19 – 22 May 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12051
2013
Conference Publication
The Microphthalmia-Associated Transcription Factor (MITF) Regulates the Proliferative Architecture of the Melanoma Microenvironment
Haass, N., Beaumont, K., Anfosso, A., Hill, D., Jurek, R., Mrass, P., Munoz, M., Kinjyo, I., Miyawaki, A. and Weninger, W. (2013). The Microphthalmia-Associated Transcription Factor (MITF) Regulates the Proliferative Architecture of the Melanoma Microenvironment. 8th World Congress of Melanoma, 9th Congress of the European Association of Dermatology (EADO), 7th Interdisciplinary Melanoma/Skin Cancer Meeting, 3rd European Post-Chicago Melanoma Meeting 2013, Hamburg, Germany, 17 - 20 July 2013. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/ddg.12161
2012
Conference Publication
Optimization of Endoplasmic Reticulum (Er) Stress-Inducing Therapies for Melanoma Using Real-Time Cell Cycle Imaging
Hill, D. S., Anfosso, A., Kinjyo, I., Lovat, P. E., Kanagawa, O. and Haass, N. K. (2012). Optimization of Endoplasmic Reticulum (Er) Stress-Inducing Therapies for Melanoma Using Real-Time Cell Cycle Imaging. 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston Ma, Nov 02-06, 2007. JOHN WILEY & SONS INC.
2012
Conference Publication
Rab27A Regulates Melanoma Proliferation and Invasion
Beaumont, K. A., Weninger, W. and Haass, N. K. (2012). Rab27A Regulates Melanoma Proliferation and Invasion. WILEY-BLACKWELL.
Funding
Supervision
Availability
- Professor Nikolas Haass is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Understanding the interplay of MITF, TFEB and CDK4/6 on lysosome activity in melanoma
Principal Advisor
Other advisors: Associate Professor Jason Lee
-
Doctor Philosophy
Proteomics and transcriptomics analysis of phenotypic heterogeneity in 3D melanoma spheroids
Principal Advisor
Other advisors: Dr Quan Nguyen, Associate Professor Helmut Schaider
-
Doctor Philosophy
Assessment of cell cycle phase-dependent immunogenicity of melanoma treated with the proteasome inhibitor bortezomib
Principal Advisor
Other advisors: Professor Brian Gabrielli
-
Doctor Philosophy
Proteomics and transcriptomics analysis of phenotypic heterogeneity in 3D melanoma spheroids
Principal Advisor
Other advisors: Dr Quan Nguyen, Associate Professor Helmut Schaider
-
Doctor Philosophy
Modulating phenotypic melanoma heterogeneity and lymphocyte infiltration to improve both targeted and immune therapy
Principal Advisor
Other advisors: Professor Brian Gabrielli, Dr Janin Chandra
-
Doctor Philosophy
Targeting epigenetic regulation to overcome immunotherapy resistance in cutaneous melanoma
Associate Advisor
Other advisors: Professor Kiarash Khosrotehrani, Dr Abbas Shafiee, Associate Professor Jason Lee
-
Doctor Philosophy
Strategies to improve immunotherapy for patients with glioblastoma or breast cancer brain metastases
Associate Advisor
Other advisors: Dr Jodi Saunus, Professor Fiona Simpson
Completed supervision
-
2023
Doctor Philosophy
Enhancing ER stress induced apoptosis and immunogenic cell death in melanoma
Principal Advisor
-
2019
Doctor Philosophy
Investigation of Microphthalmia-Associated Transcription Factor (MITF)-driven tumour heterogeneity in a 3D melanoma spheroid model in vitro.
Principal Advisor
Other advisors: Associate Professor Helmut Schaider
-
2023
Doctor Philosophy
The regulation of cGAS during cell cycle
Associate Advisor
Other advisors: Professor Paul Clarke
-
2022
Doctor Philosophy
Regulation of Microtubules in 3D by CLASPs
Associate Advisor
Other advisors: Dr Samantha Stehbens
-
2017
Doctor Philosophy
Mechanisms and markers of CHK1 inhibitors sensitivity in melanoma
Associate Advisor
Other advisors: Professor Brian Gabrielli
Media
Enquiries
For media enquiries about Professor Nikolas Haass's areas of expertise, story ideas and help finding experts, contact our Media team: